Vincerx Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Vincerx Pharma's estimated annual revenue is currently $8.8M per year.
- Vincerx Pharma's estimated revenue per employee is $384,522
Employee Data
- Vincerx Pharma has 23 Employees.
- Vincerx Pharma grew their employee count by -36% last year.
Vincerx Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Biometrics | Reveal Email/Phone |
2 | Head medicinal chemistry | Reveal Email/Phone |
3 | Head Target Discovery, non-clinical Biology, Pharmakology & DMPK | Reveal Email/Phone |
4 | SVP Clinical Development | Reveal Email/Phone |
5 | Senior Director Chemical Development | Reveal Email/Phone |
6 | Sr. Director Medical Safety Systems | Reveal Email/Phone |
7 | Senior Director, Head Statistical Programming | Reveal Email/Phone |
8 | Associate Director Clinical Operations | Reveal Email/Phone |
9 | Director Clinical Programming and Data Science | Reveal Email/Phone |
10 | Senior Director, Informatics Support & QMS Infrastructure | Reveal Email/Phone |
Vincerx Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 542 | -3% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1634 | -2% | N/A | N/A |
#10 | $10.5M | 48 | 12% | N/A | N/A |
What Is Vincerx Pharma?
Vincerx is a clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer.
keywords:N/A
N/A
Total Funding
23
Number of Employees
$8.8M
Revenue (est)
-36%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vincerx Pharma News
2022-04-06 - Vincerx Pharma Highlights VIP152 Preclinical, Clinical Data In
Gynecological Cancers - Benzinga
Vincerx Pharma Highlights VIP152 Preclinical, Clinical Data In Gynecological Cancers ... [TODAY ONLY] Get 50% OFF and get 2 bear market-beating...
2022-04-06 - Vincerx Pharma Presents Preclinical and Preliminary Clinical ...
Vincerx Pharma Presents Preclinical and Preliminary Clinical Data on PTEFb/CDK9 Inhibitor VIP152 in Gynecologic Malignancies at the American...
2022-03-30 - Vincerx Pharma Reports Fourth Quarter and Full Year 2021 ...
About Vincerx Pharma, Inc. Vincerx Pharma, Inc. (Vincerx) is a clinical-stage life sciences company focused on leveraging its extensive...
Other Companies in Palo Alto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.3M | 23 | 28% | N/A |
#2 | N/A | 23 | -4% | N/A |
#3 | N/A | 23 | 15% | N/A |
#4 | $3.5M | 23 | 64% | N/A |
#5 | $2.3M | 23 | 28% | N/A |